Biogen to Acquire Apellis Pharma in $5.6 Billion Deal to Boost Rare Disease Growth
In one of the biggest biotechnology deals of 2026, Biogen has announced the acquisition of Apellis Pharmaceuticals for…
In one of the biggest biotechnology deals of 2026, Biogen has announced the acquisition of Apellis Pharmaceuticals for…